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Introduction: Muscular atrophy, or loss of muscle mass, is prevalent when muscle use is limited by
immobilization on earth, or in microgravity when muscle tissue is not exercised by regular loading. Oxidative
stress increases with limited muscle use and as astronauts are exposed to ionizing radiation during space travel.
This oxidative stress kills muscles cells, causing even further breakdown of the tissue and damage to DNA,
increasing cancer risk. We propose that by introducing a variety of antioxidants to combat oxidative stress on
murine C2C12 muscle cells that muscular atrophy, ionizing radiation damage, and cell death can be greatly
reduced.
Materials and Methods: Several antioxidants (including DL-alpha tocopherol phosphate disodium salt (VE),
mesobiliverdin (MBV), and L-glutathione (GSH)) were tested against a uric acid standard in an OxiSelect Total
Antioxidant Capacity (TAC) Assay Kit purchased from Cell Biolabs, Inc. MBV had been tested previously at
40µM, 20µM, 10µM, 5µM, and 2.5µM to find toxicity levels. 10µM has been further tested in a rotary cell
bioreactor to test its resistance against oxidative stress to C2C12 cells when exposed to cesium-137 radiation,
suspended in simulated microgravity, and in a combination of radiation and microgravity. GSH and VE were both
tested at concentrations of 400µM, 200µM, 100µM, 50µM, and 25µM, respectively. Prior to the TAC assay, cells
were cultured with 10µM MBV and 133µM GSH, each in 2%FBS/DMEM against 133µM H2O2 in separate wells.
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Figure 1. TAC Assay results for uric acid, MBV, and GSH, standardized to uric
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reducing equivalents (CRE)
(at 0.2mM). GSH mimicked uric acid closely to as high as 1000 CRE (at 0.45mM). VE results were skewed due
to an inability to fully dissolve the powder into solution. The results for both MBV and GSH are promising
possibilities for use against oxidative stress from microgravity and radiation exposure.
Conclusion: Future experimentation with MBV, GSH, and VE will include aseptic cell culture with H2O2 to test
how effectively the antioxidants aid in resisting cell death and oxidative stress from radicals. As MBV has already
expressed promising results, we assume that at equivalent relative concentrations the GSH and VE will express
similar capabilities.
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